Pet/Veterinary Diagnostic
Nowadays, the market of In vitro diagnostic for animals is mainly in developed countries in Europe and the United States, and the market in emerging countries has grown rapidly in recent years, which is mainly driven by younger and elder generation who want more companions from their family. According to the data showed, the total global market size of animal diagnostics has been upto 37 billion US dollars in 2021, of which about 4.6 billion US dollars will be for diagnosis and treatment, with the penetration rate of ~ 12.4%, but only 9% penetration rate in the Asia-Pacific region with market size of estimated 540 million US dollars.
The " Industry Research Report for China Veterinary Diagnostic Products " released by iResearch pointed out that the size of China pet disease diagnosis and treatment market is estimated to be 11 billion yuan in 2022, and it will exceed 18 billion yuan in the future. Among them, the market size of pet in vitro diagnosis and treatment is about 6.1 billion yuan, with >20% CAGR, and is expected to reach 9 billion yuan in 2025.
From new product research, process optimization to large-scale manufacturing in our own factories, DxPartner can provide high-quality and stable materials and solutions according to the specific needs of customers to achieve timeliness and cost-effectiveness. The following are the relevant biomarker which can be developed by DxPartner for small animal diagnostic. Please contact us if needed
The " Industry Research Report for China Veterinary Diagnostic Products " released by iResearch pointed out that the size of China pet disease diagnosis and treatment market is estimated to be 11 billion yuan in 2022, and it will exceed 18 billion yuan in the future. Among them, the market size of pet in vitro diagnosis and treatment is about 6.1 billion yuan, with >20% CAGR, and is expected to reach 9 billion yuan in 2025.
From new product research, process optimization to large-scale manufacturing in our own factories, DxPartner can provide high-quality and stable materials and solutions according to the specific needs of customers to achieve timeliness and cost-effectiveness. The following are the relevant biomarker which can be developed by DxPartner for small animal diagnostic. Please contact us if needed
Category |
|
Biomarker |
Species |
Inflammation |
|
cCRP |
Canine |
|
FSAA |
Feline |
|
Pathogen |
|
CDV-Ag |
Canine |
|
CPV-Ag |
Canine |
|
|
CCV-Ag |
Canine |
|
|
FPV-Ag |
Feline |
|
|
FHV-Ag |
Feline |
|
|
FCV-Ag |
Feline |
|
|
FCoV-Ag |
Feline |
|
|
CLV-Ag |
Canine |
|
|
FeLV-Ag |
Feline |
|
Antibody |
|
CPV-Ab |
Canine |
|
CDV-Ab |
Canine |
|
|
CAV-Ab |
Canine |
|
|
cLSH-Ab |
Canine |
|
|
FPV-Ab |
Feline |
|
|
FHV-Ab |
Feline |
|
|
FCV-Ab |
Feline |
|
|
FTOXO IgM/IgG |
Feline |
|
|
CTOXO IgM/IgG |
Canine |
|
|
FIV-Ab |
Feline |
|
Others |
|
cPL |
Canine |
|
fPL |
Feline |
|
|
cTT4 |
Canine |
|
|
fTT4 |
Feline |
|
|
cTSH |
Canine |
|
|
cCOR |
Canine |
|
|
cNT-proBNP |
Canine |
|
|
cProg |
Canine |
|
|
cRIN |
Canine |
|
|
fNT-proBNP |
Feline |
